Josseline Kaplan

Title: Josseline Kaplan: Pioneering Visionary in the World of Retinal Therapies

Introduction:

Josseline Kaplan, a visionary inventor based in Paris, FR, has made significant contributions to the field of retinal therapies through his innovative work. With a total of 6 patents to his name, Kaplan’s relentless drive for innovation has left a lasting impact on the world of technology.

Latest Patents:

Kaplan's latest patents showcase his expertise in the realm of retinal therapies. One of his recent inventions includes methods for performing antisense oligonucleotide-mediated exon skipping in the retina of a subject in need. This method involves injecting antisense oligonucleotides into the vitreous of the subject to achieve exon skipping in retina cells, offering promising advancements in treating retinal disorders.

Another notable patent by Kaplan is focused on the treatment of Leber congenital amaurosis, specifically targeting patients with the mutation c.2991+1655 A>G in the CEP290 gene. His method involves administering antisense oligonucleotides to prevent splicing of the cryptic exon inserted into the mutant mRNA, thereby providing new avenues for treating this genetic condition.

Career Highlights:

Throughout his career, Kaplan has made significant contributions to renowned institutions such as Genethon and Universite Paris Descartes, where he honed his skills and expertise in the field of molecular biology and genetic therapies. His dedication to advancing retinal therapies has propelled him to the forefront of innovation in the medical industry.

Collaborations:

Working alongside esteemed colleagues such as Jean-Michel Rozet and Isabelle Perrault, Kaplan has fostered a collaborative environment that encourages creativity and excellence in research. His ability to collaborate with fellow experts has led to groundbreaking discoveries and innovative solutions in the field of retinal therapies.

Conclusion:

Josseline Kaplan's passion for innovation and his relentless pursuit of excellence have solidified his legacy as a visionary inventor in the realm of retinal therapies. His groundbreaking patents and collaborative efforts serve as an inspiration for future generations to push the boundaries of what is possible in the field of technology and medical research.